Dental Bone Graft Substitutes Market Size, Share & Trends Analysis | India | 2025-2031 | Includes: Barrier Membranes, Antimicrobial Periodontal Treatment, and 2 more

The Indian dental bone graft substitute (DBGS) and other biomaterials market was valued at over $56 million in 2024. It is projected to grow, reaching nearly $151 million by 2031.

This report covers dental bone graft substitutes, dental barrier membranes, local antimicrobial periodontal treatments, and dental soft tissue wound care-collectively referred to as the dental biomaterials market. It provides comprehensive analysis across unit sales, average selling prices (ASPs), market size, growth rates, and company shares, and includes forecasts through 2031 and historical data back to 2021.

India's market is among the fastest growing globally due to expanding dental implant adoption, broader clinician training, and rising consumer awareness of regenerative procedures. The surge in dental tourism and private clinic investment is further boosting demand for advanced biomaterials, particularly synthetic and xenograft DBGS products and dental barrier membranes.

Market Overview

The Indian dental biomaterials market is in a strong expansion phase, supported by demographic and economic trends. A growing middle class, increased aesthetic awareness, and greater access to dental implant procedures are driving the uptake of regenerative dental products.

Historically, India's DBGS market has been dominated by synthetic materials due to cost advantages and availability. However, the xenograft segment has expanded steadily in recent years, gaining clinician confidence through improved sterilization, clinical outcomes, and branding from established global manufacturers.

An important shift underway in India is the rising acceptance and adoption of dental barrier membranes. While these products have historically lagged in penetration compared to DBGS materials, they are now being recognized as an essential component of guided bone regeneration (GBR) and guided tissue regeneration (GTR) procedures. Educational initiatives and company-driven workshops are accelerating the uptake of these materials, particularly resorbable collagen membranes.

The market's structure reflects a mix of global leaders such as Geistlich, Straumann Group, and Halma, alongside domestic distributors and regional players. Local partnerships and distribution alliances are critical due to India's fragmented dental infrastructure and procurement channels.

Overall, growth is being driven by a combination of rising implant procedure volumes, growing patient awareness, and strong marketing by international and domestic suppliers, positioning India as one of the most promising dental biomaterials markets in the Asia-Pacific region.

Market Drivers

Growth of Dental Implant Procedures

Dental bone grafting is integral to implantology, supporting bone volume restoration before or during implant placement. As implant adoption accelerates in India's private dental sector, the demand for DBGS materials continues to expand.

While not every implant requires a bone graft, a significant proportion of cases-especially in posterior maxilla and mandible regions-benefit from grafting to ensure long-term stability. This structural link between implant placement and bone grafting ensures that DBGS demand rises alongside implant procedure growth.

Growing Consumer Awareness

Public awareness of dental implantology and regenerative procedures has increased markedly. Patients are becoming more informed about treatment options through digital channels and educational campaigns sponsored by implant and biomaterial manufacturers.

This expanding knowledge base has elevated both clinical acceptance and consumer trust, driving steady procedural adoption of DBGS and barrier membrane products.

Bundling and Portfolio Expansion

Leading dental companies are leveraging product bundling strategies to cross-sell DBGS materials, membranes, and implant systems. Many global firms-including Geistlich, Straumann, and Halma-offer regenerative materials alongside implants, encouraging clinicians to source complementary products from a single supplier.

These partnerships simplify logistics for dental clinics and enhance procedural consistency. For example, Geistlich's Bio-Gide(R) membranes are commonly used with its Bio-Oss(R) xenografts, while Straumann promotes its Bone Ceramic(R) material as part of its implant regeneration package.

Such integration of implants and biomaterials portfolios enhances sales synergy and drives higher overall market penetration.

Private Healthcare Growth and Dental Tourism

India's private healthcare expansion and booming dental tourism sector have amplified investment in advanced dental technologies. Clinics catering to international and affluent domestic patients increasingly adopt premium DBGS and membrane materials to ensure predictable aesthetic outcomes.

With competitive pricing and growing international reputation, India has become a favored destination for implant procedures, further bolstering demand for regenerative materials.

Market Limiters

Improvements in Oral Health

Preventive dental awareness is improving across India due to government and NGO-led oral hygiene campaigns. While this is beneficial from a public health standpoint, it may slow long-term demand for restorative and regenerative procedures.

Nevertheless, rising aesthetic expectations and tooth replacement demand among urban populations continue to sustain procedural volume growth despite better preventive care.

Lack of Insurance Coverage

Unlike in many developed markets, dental biomaterial procedures in India are not covered by public health insurance. Patients must pay the entire cost of grafting and membrane placement out of pocket.

This financial burden limits the adoption of high-cost xenograft and allograft products, particularly outside major metropolitan centers. As a result, price-sensitive synthetic grafts remain the dominant choice for most private practitioners.

Concerns About Disease Transmission

Cultural and professional apprehension about disease transmission from human or animal sources continues to influence clinician preferences. Although sterilization and safety standards have advanced, the perception of risk persists, particularly in smaller cities.

Any reports of infection or issues in tissue sourcing can quickly reduce clinician confidence, leading to temporary shifts back to synthetic or autogenous grafts.

Infrastructure and Training Gaps

Despite major progress in dental education, access to regenerative training and specialized equipment remains uneven across India. Smaller clinics may lack the tools and confidence required for advanced grafting or membrane procedures.

This disparity reinforces regional market imbalances, with major cities like Mumbai, Delhi, and Bengaluru accounting for the majority of DBGS consumption.

Market Coverage and Data Scope

• Quantitative coverage: Market size, market shares, forecasts, growth rates, units sold, and average selling prices.
• Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews that influence procedural demand.
• Time frame: Base year 2024, forecasts to 2031, and historical data from 2021 to 2023.
• Data sources: Primary interviews with industry leaders, government and regulatory data, hospital and private clinic sources, import/export databases, and iData Research's proprietary MedTech dataset.
• Method note: Market revenue is modeled from units X ASP, validated with procedural and clinical utilization data.

Care settings analyzed include private dental clinics, multispecialty hospitals, and academic institutions.

Markets Covered and Segmentation

Dental Bone Graft Substitutes (DBGS)

• By type: Mineralized allografts, demineralized bone matrix (DBM) allografts, xenografts, synthetics.

Dental Barrier Membranes

• By type: Resorbable, non-resorbable.
• By material: Allograft, xenograft, synthetic.

Antimicrobial Periodontal Treatment

Includes locally applied antimicrobial agents used to control infection and promote periodontal healing.

Dental Soft Tissue Wound Care

• By type: Plug, tape, foam.

Segment analyzed at the unit level only.

Each subcategory includes market values, units sold, ASPs, and forecast growth rates.

Competitive Analysis

Geistlich Pharma AG led the Indian dental biomaterials market in 2024. Its flagship xenograft product, Bio-Oss(R), is widely regarded as the gold standard for bone regeneration. Geistlich's complementary Bio-Gide(R) membrane line further reinforces its leadership by dominating the resorbable membrane segment.

Despite broader economic pressures that encouraged some clinicians to explore lower-cost alternatives, Geistlich retained its top position through consistent clinical education programs and a strong reputation among academic institutions.

Halma plc ranked second, driven by its success in the synthetic DBGS segment. Through its specialized subsidiaries, Halma has effectively promoted affordable synthetic graft materials that appeal to India's value-oriented market. Its exclusive distribution agreement with ZimVie Dental since 2018 strengthened its reach and product credibility among implant specialists.

Straumann Group held a notable market share in 2024, with a strategic focus on synthetic and biphasic materials. Its Bone Ceramic(R)-a combination of hydroxyapatite (HA) and beta-tricalcium phosphate (B-TCP)-was promoted as a regenerative complement to Straumann's implant systems. This integration allowed clinicians to streamline implant planning with compatible regenerative solutions.

Straumann's Neodent(R) brand, positioned as a cost-effective implant line, also enhanced visibility and cross-selling opportunities for the company's DBGS and membrane products.

Overall, the competitive environment is dynamic, with global leaders competing alongside local distributors and emerging Indian manufacturers. The high-growth environment encourages partnerships, distribution expansion, and portfolio diversification.

Technology and Practice Trends

• Shift toward barrier membrane use: Dental membranes, once considered optional, are now viewed as essential for predictable GBR outcomes.
• Resorbable membranes gaining traction: Collagen-based resorbable membranes dominate new product introductions due to handling simplicity and patient comfort.
• Synthetic material optimization: Manufacturers continue improving porosity, resorption rates, and biocompatibility of synthetic grafts to emulate natural bone regeneration.
• Training integration: Dental implant courses now incorporate grafting and membrane modules, ensuring practitioners learn evidence-based regenerative protocols early in their careers.
• Bundled offerings: Implant manufacturers increasingly integrate regenerative portfolios, offering turnkey surgical kits that include grafts and membranes.
• Urban concentration of adoption: High-end regenerative procedures are concentrated in Tier 1 cities, while price-sensitive synthetic materials are expanding in Tier 2 and 3 markets.

Collectively, these trends underline India's transition from a cost-driven to a clinically driven dental biomaterials market.

Geography

This edition focuses on India.

96 pages of in-depth narrative, tables, and charts.

Why This Report

Where is the fastest-growing opportunity within India's dental biomaterials market?

How are synthetic and xenograft materials competing in clinical adoption?

Which barrier membrane products are expanding most rapidly in India's implant-driven market?

What is the impact of pricing, education, and distribution partnerships on adoption rates?

How do cultural factors and public reimbursement gaps shape product demand?

Which companies are leading in market share, and how are they positioning for growth through 2031?

How can suppliers bundle implants and biomaterials to maximize market presence?

What risks may limit future growth, and how can companies mitigate them through clinical training and communication?

The India Dental Bone Graft Substitute and Other Biomaterials Market Report from iData Research answers these questions with procedure-based modeling, pricing data, and competitive share analysis.

Use it to quantify demand, plan new product entries, and benchmark strategies in one of the world's fastest-growing dental markets.